Suchergebnisse - "Subklewe, Marion"

PubPharm (31)

1

Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality

enthalten in: Blood advances | 2024

von Rejeski, K. | Wang, Y. | Hansen, D. | +14

2

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

enthalten in: Blood cancer discovery | 2024

von Faramand, R. | Lee, S. | Jain, M. | +30

3

Management of Patients Undergoing CAR-T Cell Therapy in Germany

enthalten in: Oncology research and treatment | 2024

von Penack, O. | Dreger, P. | Ajib, S. | +16

4

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Iacoboni, G. | Navarro, V. | Martín-López, A. | +21

5

Recognizing, defining, and managing CAR-T hematologic toxicities

enthalten in: Hematology. American Society of Hematology. Education Program | 2023

von Rejeski, K. | Subklewe, M. | Locke, F.

6

Mechanisms and strategies for safe chimeric antigen receptor T-cell activity control

enthalten in: International journal of cancer | 2023

von Stock, S. | Klüver, A. | Fertig, L. | +4

7

Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy

enthalten in: Journal for immunotherapy of cancer | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

8

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

enthalten in: Science advances | 2023

von Rejeski, K. | Perez, A. | Iacoboni, G. | +23

9

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy

enthalten in: Cytotherapy | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

10

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

enthalten in: Journal of hematology & oncology | 2023

von Rejeski, K. | Hansen, D. | Bansal, R. | +15